Livadas assumed his current role in September 2023 to lead the four legal entities under the company’s pharma sector umbrella: SITCO Pharma, AJA Pharma, Chemical Company for Commercial Investment, and Care Supply Chain for Logistics Services. In Q4 2023, AJA Pharma launched the locally packaged medicine “Panadol Extra” in Saudi Arabia. It also signed an agreement with Dr. Reddy’s Laboratories to acquire the registration and marketing rights for three injectable products in Saudi Arabia and the GCC. Before joining the company, Livadas spent 15 years with Eli Lilly and Company.